MM

Manishkumar Mavjibhai Shyal

Active Director Director DIN 08876297
DIN 08876297 First appointment Sep 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Manishkumar Mavjibhai Shyal

Data last updated:

Manishkumar Mavjibhai Shyal is a Director at Brainzome Technolabs Private Limited (since 2020). The company operates in Healthcare.

DIN 08876297
Primary Designation Director
Industry Healthcare
First Appointment 12 Sep 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Brainzome Technolabs Private Limited U85100GJ2020PTC116481
Director12 Sep 20202020Active

Board colleagues of Manishkumar Mavjibhai Shyal

Directorship timeline

Open interactive timeline →
Brainzome Technolabs Private Limited
Premium access

Shareholding and investment profile for Manishkumar Mavjibhai Shyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manishkumar Mavjibhai Shyal

Manishkumar Mavjibhai Shyal currently holds 1 directorship: Brainzome Technolabs Private Limited (Director, since 12 Sep 2020).

Manishkumar Mavjibhai Shyal was first appointed on 12 Sep 2020 as Director at Brainzome Technolabs Private Limited.

The current boards of Manishkumar Mavjibhai Shyal's companies include Bambhaniya Anilbhai Bhayabhai (Brainzome Technolabs Private Limited), Kartikbhai Hareshbhai Gohel (Brainzome Technolabs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available